Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences Stock Tumbles, Highlights Slowdown In TAVR Business
02:36pm, Thursday, 25'th Jul 2024
Edwards Lifesciences Corp EW reported Wednesday second-quarter adjusted EPS of 70 cents, beating the consensus of 69 cents.
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
01:36pm, Thursday, 25'th Jul 2024
Edwards Lifesciences Corporation EW reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
10:06am, Thursday, 25'th Jul 2024
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.
Why Is Edwards Lifesciences (EW) Stock Down 22% Today?
08:36am, Thursday, 25'th Jul 2024
Edwards Lifesciences (NYSE: EW ) stock is down on Thursday after the heart disease care company announced earnings for its second quarter of 2024. That earnings report starts with its adjusted EPS of
Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences
08:30am, Thursday, 25'th Jul 2024
Peijia to maintain exclusive rights in Greater China to commercialize JenaValve's Trilogy Transcatheter Heart Valve (THV) System SUZHOU, China , July 25, 2024 /PRNewswire/ -- Peijia Medical Limited (P
Edwards Lifesciences Stock Plunges 24% After Earnings. What Wall Street Thinks.
07:53am, Thursday, 25'th Jul 2024
The medical-technologies company misses second-quarter sales estimates.
Edwards Lifesciences Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Edwards Lifesciences (EW)
07:25am, Thursday, 25'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning
Edwards Lifesciences Corporation (EW) Q2 2024 Earnings Call Transcript
09:45pm, Wednesday, 24'th Jul 2024
Edwards Lifesciences Corporation (NYSE:EW ) Q2 2024 Earnings Conference Call July 24, 2024 5:00 PM ET Company Participants Mark Wilterding - SVP & IR Bernard Zovighian - CEO Scott Ullem - CFO Larry Wo
Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
07:00pm, Wednesday, 24'th Jul 2024
While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics
Edwards Lifesciences (EW) Q2 Earnings Match Estimates
06:25pm, Wednesday, 24'th Jul 2024
Edwards Lifesciences (EW) came out with quarterly earnings of $0.70 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago.
Edwards Lifesciences misses Q2 revenue estimates on weak demand for heart devices
05:52pm, Wednesday, 24'th Jul 2024
Edwards Lifesciences missed second-quarter revenue estimates on Thursday, hurt by lower-than-expected demand for its artificial heart valves.
Edwards Lifesciences Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EW
07:20am, Wednesday, 24'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning
Can These 4 MedTech Stocks Hit Targets This Earnings Season?
01:05pm, Tuesday, 23'rd Jul 2024
Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.
Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions
12:50pm, Thursday, 18'th Jul 2024
Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet needs in structural heart disease.
Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth
11:09am, Wednesday, 17'th Jul 2024
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
